Biogen
Price & Volume
Stats
See more52W Range | $121.05-$219.72 |
Market Cap | $29.4B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $9.9B |
Revenue Growth (YoY) | 1.9% |
Gross Profit (12 Mos) | $7.8B |
Diluted EPS | $9.30 |
News
See moreYahoo Finance • 8 hours ago
Biogen nabs approval of subcutaneous version of Leqembi for initiation dose
Yahoo Finance • 9 hours ago
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease
Yahoo Finance • 14 hours ago
Stocks Retreat on Chipmaker Weakness and US-Iran Standoff
Yahoo Finance • 14 hours ago
Stock Market Today, July 13: SK Hynix Tumbles 15% in South Korea, Leading Semiconductor Drop at Midday
About
CEO | Mr. Christopher A. Viehbacher |
CFO | Ms. Robin C. Kramer |
Address | 225 Binney Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 7,500 |